Cutter Capital Management, LP Portfolio Holdings
Cutter Capital Management, LP
- $331 Billion
- Q2 2024
Cutter Capital Management, LP has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $331 Billion distributed in 27 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Biomarin Pharmaceutical Inc with a value of $22.5B, Merck & Co., Inc. with a value of $21.7B, Gilead Sciences, Inc. with a value of $20.1B, Amgen Inc with a value of $20.1B, and Royalty Pharma PLC with a value of $18.3B.
Examining the 13F form we can see an increase of $69.8B in the current position value, from $262B to 331B.
Cutter Capital Management, LP is based out at New York, NY
Below you can find more details about Cutter Capital Management, LP portfolio as well as his latest detailed transactions.